2m 2m 2m 2m 2m 2m 2m
America Gret Hlt (AAGH)
OTC
$0.000001$0.00 (0.00%)
Price as of May 19, 2026- $21,152.00Market Cap
- -99.94%1-Year Change
- BiotechnologyIndustry
America Gret Hlt (AAGH)
$0.000001$0.00 (0.00%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 391,743 +32.94% | 294,670 +44.23% | 204,308 +95.23% | 104,648 -46.52% | |
Cost of Revenue | 52,622 -57.88% | 124,920 +249.72% | 35,720 -97.75% | 1.6M +1,000.66% | |
Gross Profit | 339,121 +99.78% | 169,750 +0.69% | 168,588 +111.36% | -1.5M -2,989.42% | |
Sales and Marketing Expense | 50,866 -46.92% | 95,835 +2,296.47% | 3,999 -95.37% | 86,316 N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 14,788 -0.007% | 14,789 +42.94% | 10,346 +75.21% | 5,905 N/A | |
Total Operating Expenses | 52,622 -57.88% | 124,920 +249.72% | 35,720 -97.75% | 1.6M +438.62% | |
Operating Profit | -382,935 -51.08% | -782,700 +58.88% | -492,644 -89.59% | -4.7M +1,843.71% | |
Interest Income | 46 -24.59% | 61 +134.62% | 26 +420.00% | 5 N/A | |
Interest Expense | -241,120 -63.49% | -660,439 +106.58% | -319,705 +67.46% | -190,916 +852.48% | |
Interest Income and Expense and Net | -241,074 -63.49% | -660,378 +106.58% | -319,679 +67.45% | -190,911 +852.46% | |
Total Nonoperating Income and Expense | -338,307 -23.75% | -443,662 +55.84% | -284,696 +49.18% | -190,838 +648.56% | |
Income before Taxes | -721,242 -41.19% | -1.2M +57.76% | -777,340 -84.22% | -4.9M +1,730.46% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -719,119 -41.08% | -1.2M +57.02% | -777,340 -84.22% | -4.9M +1,730.46% | |
Net Income from Continuing Operations Applicable to Common | -721,242 -41.19% | -1.2M +61.06% | -761,420 -84.35% | -4.9M +1,708.62% | |
Basic EPS and Net Income | 0.00 N/A | 0.00 N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | 21.1B +0.10% | 21.1B +0.14% | 21.1B +0.02% | 21.1B +3.19% | |
Diluted Weighted Average Shares | 21.1B +0.10% | 21.1B N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 44,056 -19.82% | 54,943 +1.46% | 54,150 -13.56% | 62,643 -84.19% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 44,056 -19.82% | 54,943 +1.46% | 54,150 -13.56% | 62,643 -84.19% | |
Total Current Assets | 236,712 +4.98% | 225,479 +25.64% | 179,465 -8.71% | 196,585 -59.33% | |
Accumulated Depreciation | 45,828 +47.64% | 31,040 N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 28,115 -34.47% | 42,903 -25.63% | 57,692 +144.27% | 23,618 +86.39% | |
Total Long-Term Assets | 28,115 N/A | 0 -100.00% | 8,218 -40.60% | 13,836 +9.19% | |
Total Assets | 301,817 -6.70% | 323,478 +8.14% | 299,129 -11.01% | 336,143 -46.05% | |
Income Taxes Payable | 3,836 +127.66% | 1,685 -57.56% | 3,970 +3,792.16% | 102 -87.25% | |
Total Short-Term Debt | 595,072 -1.96% | 606,978 -13.93% | 705,216 -6.94% | 757,791 +134.07% | |
Total Current Liabilities | 3.8M +6.33% | 3.6M +16.22% | 3.1M +12.13% | 2.8M +537.66% | |
Total Long-Term Debt | 2.2M +21.33% | 1.8M +63.25% | 1.1M +8.82% | 1.0M +77.29% | |
Total Long-Term Liabilities | 2.2M +8.97% | 2.0M +17.81% | 1.7M +20.42% | 1.4M +118.59% | |
Total Liabilities | 6.0M +7.29% | 5.6M +16.79% | 4.8M +14.97% | 4.2M +284.71% | |
Retained Earnings | -10.8M +5.20% | -10.2M +11.60% | -9.2M +9.04% | -8.4M +136.86% | |
Total Stockholders Equity | -5.7M +8.22% | -5.2M +17.52% | -4.5M +17.08% | -3.8M +712.63% | |
Total Shares Outstanding | 21.2B +0.07% | 21.1B +0.14% | 21.1B +0.08% | 21.1B +0.09% | |
Cash Flow | |||||
Cash from Operating Activities | -332,862 -45.93% | -615,627 -18.23% | -752,902 -49.12% | -1.5M +349.48% | |
Capital Expenditures | N/A N/A | 0 -100.00% | 44,420 +163.60% | 16,851 +32.99% | |
Cash from Investing Activities | 0 N/A | 0 +100.00% | -44,420 +163.60% | -16,851 +32.99% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 321,532 -47.92% | 617,403 -21.78% | 789,328 -32.13% | 1.2M +57.62% | |
Financials Ratio | |||||
Gross Margin | 86.57% +50.27% | 57.61% -30.19% | 82.52% +105.82% | -1,417.90% -5,502.64% | |
Operating Margin | -97.75% -63.20% | -265.62% +10.16% | -241.13% -94.67% | -4,523.83% +3,534.35% | |
Return on Assets | -230.01% -41.34% | -392.08% +60.21% | -244.73% -76.17% | -1,026.93% +1,096.40% | |
Return on Equity | 13.20% -47.63% | 25.21% +33.84% | 18.84% -91.83% | 230.70% +192.75% | |
Revenue Growth | 32.94% -25.52% | 44.23% -53.56% | 95.23% +304.72% | -46.52% -101.34% | |
Current Ratio | 0.06 -1.12% | 0.06 +8.10% | 0.06 -18.65% | 0.07 -93.62% | |
Cash Ratio | 0.01 -24.84% | 0.02 -12.57% | 0.02 -22.91% | 0.02 -97.52% | |
Debt-to-Equity Ratio | -0.50 +6.77% | -0.47 +13.56% | -0.41 -12.74% | -0.47 -75.69% | |
Debt-to-Assets Ratio | 9.34 +23.83% | 7.54 +23.43% | 6.11 +14.79% | 5.32 +266.20% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow